Document is current

Any future updates will be listed below

Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies

Crossref DOI link: https://doi.org/10.1007/s40257-026-01059-6

Published Online: 2026-07-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark